Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Ending Cash Position : ¥1,073 Mil (As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Tonghua Dongbao Pharmaceutical Co Ending Cash Position?

Tonghua Dongbao Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 was ¥1,073 Mil.

Tonghua Dongbao Pharmaceutical Co's quarterly Ending Cash Position increased from Sep. 2023 (¥662 Mil) to Dec. 2023 (¥1,104 Mil) but then declined from Dec. 2023 (¥1,104 Mil) to Mar. 2024 (¥1,073 Mil).

Tonghua Dongbao Pharmaceutical Co's annual Ending Cash Position declined from Dec. 2021 (¥865 Mil) to Dec. 2022 (¥788 Mil) but then increased from Dec. 2022 (¥788 Mil) to Dec. 2023 (¥1,104 Mil).

Tonghua Dongbao Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Tonghua Dongbao Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tonghua Dongbao Pharmaceutical Co Ending Cash Position Chart

Tonghua Dongbao Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

297.14

392.03

865.04

788.06

1,104.20

Tonghua Dongbao Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Ending Cash Position	Get a 7-Day Free Trial															858.22	518.17	662.33	1,104.20	1,073.28

Tonghua Dongbao Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Tonghua Dongbao Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	788.061	+	316.143
	=	1,104

Tonghua Dongbao Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1104.204	+	-30.928
	=	1,073

Tonghua Dongbao Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Tonghua Dongbao Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tonghua Dongbao Pharmaceutical Co Ltd (SHSE:600867) » Definitions » Ending Cash Position

Traded in Other Exchanges

N/A

Address

Dongbao Village, Jilin Province, Tonghua, CHN, 134123

Website

http://www.thdb.com

Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.

Executives

Cheng Jian Qiu	Supervisors
Chang Xiao Hui	Director
Li Cong	Director
Li Feng Qin	Director
Chen Hong	senior management
Leng Chun Sheng	Director
Li Yi Kui	Director
Wang Dian Duo	Supervisors
Wang Jun Ye	Director
Han Jie	Director

Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Headlines

No Headlines